Ignite Creation Date:
2025-12-24 @ 11:19 PM
Ignite Modification Date:
2025-12-25 @ 9:01 PM
Study NCT ID:
NCT02410356
Status:
TERMINATED
Last Update Posted:
2021-12-10
First Post:
2015-03-30
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
Sponsor:
Teva Branded Pharmaceutical Products R&D, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-04-30
Start Date Type:
ACTUAL
Primary Completion Date:
2016-02-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-04-30
Completion Date Type:
ACTUAL
First Submit Date:
2015-03-30
First Submit QC Date:
None
Study First Post Date:
2015-04-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2018-04-18
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2021-12-08
Last Update Post Date:
2021-12-10
Last Update Post Date Type:
ACTUAL